Plant-based diet and supplements for smoldering myeloma or MGUS
Treatments studied
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study tests whether a plant-based diet and certain supplements can help people with smoldering multiple myeloma (SMM) or monoclonal gammopathy of undetermined significance (MGUS). Participants will learn to cook plant-based recipes and track their meals using a phone app.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with MGUS or smoldering multiple myeloma (confirmed within the last 6 months).
- You are 18 years or older.
- You are willing to follow a plant-based diet and stop any extra supplements (except basic vitamins like D, B12, iron) for 2 weeks before and during the study.
- You have access to a smartphone with a camera and can download the Keenoa app.
- You live in the United States for the duration of the study and can speak English (or have an English-speaking helper).
- You are not allergic to legumes or have severe nut allergies (like peanuts or cashews).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a plant-based diet can help people with newly diagnosed multiple myeloma who are receiving a standard 4-cycle drug combination (DRVd). Researchers want to see if changing what you eat might improve treatment results.
This trial tests whether a whole-food, plant-based eating pattern—plus supplements or placebo—can improve health outcomes in people with MGUS or smoldering multiple myeloma. You may be asked to follow specific recipes and stop certain supplements, so it helps to confirm you can stick with the plan.
This study tests whether a Korean-style Mediterranean diet and tracking physical activity can help people with MGUS or smoldering multiple myeloma. Participants will follow the diet for 12 weeks and wear a device to measure their daily activity.
This study tests whether a special diet—longer nightly fasting plus a Mediterranean eating pattern—can help people with multiple myeloma or its early stages. If you qualify, you will be randomly assigned to start the diet right away or join a waitlist group.
This study looks at how patients feel day to day (quality of life) while they are monitored or treated for MGUS or smoldering multiple myeloma. It is designed for people who do NOT yet have “myeloma defining events” or amyloidosis, because the goal is to understand well-being in earlier disease stages.
This study looks at two different “precursor” conditions that can happen before multiple myeloma: MGUS and smoldering myeloma (SMM). Researchers want to better tell which cases are more likely to progress, using blood/urine tests and sometimes bone marrow tissue.
Hear when a new Multiple myeloma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.